ReviewCancers2021

Immune Checkpoint Inhibitors in Urothelial Carcinoma: Recommendations for Practical Approaches to PD-L1 and Other Potential Predictive Biomarker Testing.

Antonio Lopez-Beltran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.